APOE genotype and serum cholesterol in predicting risk for early death from ischemic stroke in men and women

Cerebrovascular Diseases

Volumn 20, Issue 5, 2005, Pages 291-298

  Gromadzka, Grazyna ^a   Barańska Gieruszczak, Maria ^a   Ciesielska, Agnieszka ^a   Sarzyńska Dlugosz, Iwona ^a   Członkowska, Anna ^a,b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

APOE; Cholesterol; Genotype; Ischemic; Stroke

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE REGRESSION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEINS E; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHOLESTEROL; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEX DISTRIBUTION;

EID: 27644534545     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087927     Document Type: Article

References (33)

1. Bhalla A, Gupta OP, Gupta SB: Predicting mortality in stroke. Neurol India 2002;50:279-281.
2. Wong KS: Risk factors for early death in acute ischemic stroke and intracerebral hemorrhage. Stroke 1999;30:2326-2330.
3. Tei H, Uchiyama S, Ohara K, Kobayashi M, Uchiyama Y, Fukuzawa M: Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project. Stroke 2000;31:2049-2054.
4. Barauska M, Gromadzka AG, Ciesielska A, Mendel T, Sarzyńska- Długosz I, Członkowska A: Apolipoprotein E (ApoE) genotypes and outcome in men and women patients with cerebral ischemia. Cerebrovasc Dis 2003;16(suppl 4):7.
5. Weisgraber KH, Rall SC Jr, Mahley RW, Weisgraber KH: Human E apoprotein heterogeneity: cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem 1981;10:9077-9083.
6. Rall SC Jr, Weisgraber KH, Mahley RW: Human apolipoprotein E: the complete amino acid sequence. J Biol Chem 1982;257:4171-4178.
7. Horsburgh K, McCarron MO, White F, Nicoll JA: The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models. Neurobiol Aging 2000;21:245-255.
8. Kesaniemi YA, Ehnholm C, Miettinen TA: Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 1987;80:578-581.
9. Ehnholm C, Mahley RW, Chappell DA, Weisgraber KH, Ludwig E, Witztum JL: Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc Natl Acad Sci USA 1984;81:5566-5570.
10. Lapinleimu H, Viikari J, Ronnemaa T, Valimaki I, Tuominen J, Marniemi J, Ehnholm C, Jokinen E, Simell O: Apolipoprotein E polymorphism and serum lipids in a randomized, prospective trial of an infant diet with reduced saturated fat and cholesterol. Pediatrics 111996;98:757-762.
11. Pedro-Botet J, Senti M, Nogues X, Rubies-Prat J, Roquer J, D'Olhaberriague L, Olive J: Lipoprotein and apolipoprotein profile in men with ischemic stroke: Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 1992;23:1556-1562.
12. Souza DR, Campos BF, Arruda EF, Yamamoto LJ, Trindade DM, Tognola WA: Influence of the polymorphism of apolipoprotein E in cerebral vascular disease. Arq Neuropsiquiatr 2003;61:7-13.
13. Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ: Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 1994;272:1666-1671.
14. Stankovic S, Glisic S, Alavanatic D: The effect of a gender difference in the apolipoprotein E gene DNA polymorphism on serum lipid levels in a Serbian healthy population. Clin Chem Lab Med 2000;38:539-544.
15. Xhignesse M, Lussier-Cacan S, Sing CF, Kessling AM, Davignon J: Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler Thromb 1991;11:1100-1110.
16. Hagberg JM, Wilund KR, Ferrell RE: APOE gene and gene-environment effects on plasma lipoprotein-lipid levels. Physiol Genomics 2000;4:101-108.
17. Vauthey C, de Freitas GR, van Melle G, Devuyst G, Bogousslavsky J: Better outcome after stroke with higher serum cholesterol levels. Neurology 2000;54:1944-1949.
18. Zuliani G, Cherubini A, Atti AR, Ble A, Vavalle C, Di Todaro F, Benedetti C, Volpato S, Marinescu MG, Senin U, Fellin R: Low cholesterol levels are associated with short-term mortality in older patients with ischemic stroke. J Gerontol A Biol Sci Med Sci 2004;59:293-297.
19. Horenstein RB, Smith DE, Mosca L: Cholesterol predicts stroke mortality in the Women's Pooling Project. Stroke 2002;33:1863-1868.
20. Joseph JA, Villalobos-Molinas R, Denisova NA, Erat S, Strain J: Cholesterol: a two-edged sword in brain aging. Free Radic Biol Med 1997;22:455-462.
21. Eryurek FG, Surmen E, Oner P, Altug T, Oz H: Gamma-glutamyl transpeptidase and acetylcholinesterase activities in brain capillaries of cholesterol-fed rabbits. Res Commun Chem Pathol Pharmacol 1990;69:245-248.
22. World Health Organization (WHO): International Classification of Impairments, Disabilities and Handicaps. Geneva, World Health Organization, 1980.
23. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-1526.
24. Multicenter trial of hemodilution in ischemic stroke: background and study protocol. Scandinavian Stroke Study Group. Stroke 1985;16:885-890.
25. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
26. Miyata M, Smith JD: Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 1996;14:55-61.
27. Barger SW, Harmon AD: Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 1997;388:878-881.
28. Laskowitz DT, Goel S, Bennett ER, Matthew WD: Apolipoprotein E suppresses glial cell secretion of TNF alpha. J Neuroimmunol 1997;76:70-74.
29. Laskowitz DT, Horsburgh K, Roses AD: Apolipoprotein E and the CNS response to injury. J Cereb Blood Flow Metab 1998;18:465-471.
30. Lynch JR, Morgan D, Mance J, Matthew WD, Laskowitz DT: Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response. J Neuroimmunol 2001;114:107-113.
31. Phillips NR, Havel RJ, Kane JP: Sex-related differences in the concentrations of apolipoprotein E in human blood plasma and plasma lipoproteins. J Lipid Res 1983;24:1525-1531.
32. Garcia-Segura LM, Azcoitia I, DonCarlos LL: Neuprotection by estradiol. Prog Neurobiol 2001;63:29-60.
33. Colton CA, Brown CM, Vitek MP: Sex steroids, APOE genotype and the innate immune system. Neurobiol Aging 2005;263:363-372.